Stay updated on Secured Access to Nivolumab for Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.

Latest updates to the Secured Access to Nivolumab for Rare Cancers Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page revision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 was added to the site; the prior lapse-in-funding notice and Revision: v3.4.1 were removed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a site-wide notice about a lapse in government funding. Updated the revision to v3.4.1, replacing the previous v3.4.0 tag.SummaryDifference0.4%

- Check68 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.SummaryDifference0.2%

- Check82 days agoChange DetectedThe update adds a minor revision notice: Revision: v3.3.4 appears and Revision: v3.3.3 is removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Secured Access to Nivolumab for Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.